Smilagenin acetate
Smilagenin acetate is a sapogenin derivative extracted from patent US20030004147A1. Smilagenin acetate increases the expression of acetylcholine m2 receptors and can be used for the research of dementia[1].
Product Specifications
CAS Number
[4947-75-5]
UNSPSC
12352005
Target
MAChR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/smilagenin-acetate.html
Purity
99.68
Solubility
Ethanol : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
C[C@@]12[C@]3([H])[C@@](C[C@@]1([H])[C@@]4([H])[C@]([C@@]5([C@](C[C@H](CC5)OC(C)=O)([H])CC4)C)([H])CC2)([H])O[C@]6(CC[C@H](CO6)C)[C@H]3C
Molecular Formula
C29H46O4
Molecular Weight
458.67
References & Citations
[1]Paul Barraclough, et al. 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia. US20030004147A1.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
